Comparison of approaches for source attribution of ESBL-producing Escherichia coli in Germany

被引:13
作者
Perestrelo, Sara [1 ]
Carreira, Guido Correia [1 ]
Valentin, Lars [1 ]
Fischer, Jennie [1 ]
Pfeifer, Yvonne [2 ]
Werner, Guido [2 ]
Schmiedel, Judith [3 ]
Falgenhauer, Linda [4 ,5 ,6 ]
Imirzalioglu, Can [3 ,5 ]
Chakraborty, Trinad [3 ,5 ]
Kaesbohrer, Annemarie [1 ,7 ]
机构
[1] German Fed Inst Risk Assessment, Biol Safety, Berlin, Germany
[2] Robert Koch Inst, Nosocomial Pathogens & Antibiot Resistance, Wernigerode, Germany
[3] Justus Liebig Univ, Inst Med Microbiol, Giessen, Germany
[4] Justus Liebig Univ, Inst Hyg & Environm Med, Giessen, Germany
[5] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, Campus Giessen, Giessen, Germany
[6] Hess Univ Kompetenzzentrum Krankenhaushygiene HuK, Giessen, Germany
[7] Univ Vet Med, Vet Publ Hlth & Epidemiol, Vienna, Austria
关键词
SPECTRUM BETA-LACTAMASES; URINARY-TRACT-INFECTIONS; FOOD-PRODUCING ANIMALS; FATTENING PIG FARMS; RISK-FACTORS; KLEBSIELLA-PNEUMONIAE; BEEF-CATTLE; E.-COLI; CIPROFLOXACIN RESISTANCE; ANTIBIOTIC-RESISTANCE;
D O I
10.1371/journal.pone.0271317
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Extended-spectrum beta-lactamase (ESBL)-producing Escherichia (E.) coli have been widely described as the cause of treatment failures in humans around the world. The origin of human infections with these microorganisms is discussed controversially and in most cases hard to identify. Since they pose a relevant risk to human health, it becomes crucial to understand their sources and the transmission pathways. In this study, we analyzed data from different studies in Germany and grouped ESBL-producing E. coli from different sources and human cases into subtypes based on their phenotypic and genotypic characteristics (ESBL-genotype, E. coli phylogenetic group and phenotypic antimicrobial resistance pattern). Then, a source attribution model was developed in order to attribute the human cases to the considered sources. The sources were from different animal species (cattle, pig, chicken, dog and horse) and also from patients with nosocomial infections. The human isolates were gathered from community cases which showed to be colonized with ESBL-producing E. coli. We used the attribution model first with only the animal sources (Approach A) and then additionally with the nosocomial infections (Approach B). We observed that all sources contributed to the human cases, nevertheless, isolates from nosocomial infections were more related to those from human cases than any of the other sources. We identified subtypes that were only detected in the considered animal species and others that were observed only in the human population. Some subtypes from the human cases could not be allocated to any of the sources from this study and were attributed to an unknown source. Our study emphasizes the importance of human-to-human transmission of ESBL-producing E. coli and the different role that pets, livestock and healthcare facilities may play in the transmission of these resistant bacteria. The developed source attribution model can be further used to monitor future trends. A One Health approach is necessary to develop source attribution models further to integrate also wildlife, environmental as well as food sources in addition to human and animal data.
引用
收藏
页数:27
相关论文
共 105 条
[1]   Clonal relationship between human and avian ciprofloxacin-resistant Escherichia coli isolates in North-Eastern Algeria [J].
Agabou, A. ;
Lezzar, N. ;
Ouchenane, Z. ;
Khemissi, S. ;
Satta, D. ;
Sotto, A. ;
Lavigne, J. -P. ;
Pantel, A. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (02) :227-234
[2]   THE EMERGENCE OF HIGHLY FLUOROQUINOLONE-RESISTANT ESCHERICHIA-COLI IN COMMUNITY-ACQUIRED URINARY-TRACT INFECTIONS [J].
AGUIAR, JM ;
CHACON, J ;
CANTON, R ;
BAQUERO, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 29 (03) :349-350
[3]  
[Anonymous], 2012, IMPROVING FOOD SAFET
[4]   Occurrence and molecular characteristics of ESBL/AmpC-producing Escherichia coli in faecal samples from horses in an equine clinic [J].
Apostolakos, Ilias ;
Franz, Eelco ;
van Hoek, Angela H. A. M. ;
Florijn, Alice ;
Veenman, Christiaan ;
Sloet-van Oldruitenborgh-Oosterbaan, Marianne M. ;
Dierikx, Cindy ;
van Duijkeren, Engeline .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (07) :1915-1921
[5]   CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America [J].
Araque, Maria ;
Millan, Beatriz ;
Mendoza, Evelin ;
Salas, Marianella .
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2013, 7 (05) :432-435
[6]   Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study [J].
Arcilla, Maris S. ;
van Hattem, Jame M. ;
Haverkate, Manon R. ;
Bootsma, Martin C. J. ;
van Genderen, Perry J. J. ;
Goorhuis, Abraham ;
Grobusch, Martin P. ;
Lashof, Astrid M. Oude ;
Molhoek, Nicky ;
Schultsz, Constance ;
Stobberingh, Ellen E. ;
Verbrugh, Henri A. ;
de Jong, Menno D. ;
Melles, Damian C. ;
Penders, John .
LANCET INFECTIOUS DISEASES, 2017, 17 (01) :78-85
[7]   Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey [J].
Arslan, H ;
Azap, ÖK ;
Ergönül, Ö ;
Timurkaynak, F .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (05) :914-918
[8]   A New Clone Sweeps Clean: the Enigmatic Emergence of Escherichia coli Sequence Type 131 [J].
Banerjee, Ritu ;
Johnson, James R. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (09) :4997-5004
[9]   Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype [J].
Bevan, Edward R. ;
Jones, Annie M. ;
Hawkey, Peter M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (08) :2145-2155
[10]  
BMEL, 2019, BER BUND ERN LANDW E